What is Alchemy Creative Inc?
, an early-stage venture holding company, focuses on biopharmaceutical, edutainment, nanotechnology, and developmental research enterprises.
ALMY · Verdict
Moderate reward · elevated risk
ALMY stands out on growth and balance sheet, but watch the volatility signal.
Based on 88% data coverage
ALMY · Verdict
Revenue +12.3% CAGR
Current ratio 0.43
Above average
Weak vs peers
-94% net margin · 0% ROE
-94% net margin
Model-based scoring. For information only — not financial advice.
, an early-stage venture holding company, focuses on biopharmaceutical, edutainment, nanotechnology, and developmental research enterprises. The company was formerly known as Method Products Corp. The company is listed on the OTCCE in USA, operating in the Industrials sector, with a market capitalisation of 6.01K.
The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.